Acción ASND ASCENDIS PHARMA A/S
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Ascendis Pharma A/S

Acciones

ASND

US04351P1012

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
138,4 USD -1,22 % Gráfico intradía de Ascendis Pharma A/S -4,41 % +9,92 %
29/04 La renta variable europea cotizó en EE.UU. con recibos de depósito estadounidenses al alza el lunes MT
26/04 La renta variable europea negociada en EE.UU. como recibos de depósito estadounidenses tiende al alza en la sesión del viernes y termina la semana con una subida del 3,4 MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
Ascendis Pharma - United Kingdom's MHRA Approves YORVIPATH in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
Ascendis Pharma A/S Announces United Kingdom's MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
Ascendis Pharma A/S : Form 6-K
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday
Ascendis Pharma A/S : Form 6-K
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
Ascendis Pharma A/S : Form 6-K
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ASND
  4. Noticias Ascendis Pharma A/S
  5. Otros idiomas